Deutsche Bank
LXEO icon

Deutsche Bank’s Lexeo Therapeutics LXEO Stock Holding History

Deutsche Bank’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
82,293
+19,242
+31% +$104K ﹤0.01% 2918
2026
Q1 		$362K Buy
63,051
+5,885
+10% +$41.7K ﹤0.01% 2741
2025
Q4 		$568K Buy
57,166
+32,844
+135% +$300K ﹤0.01% 2502
2025
Q3 		$161K Buy
24,322
+400
+2% +$1.93K ﹤0.01% 3160
2025
Q2 		$96.2K Buy
23,922
+12,552
+110% +$41.3K ﹤0.01% 3273
2025
Q1 		$39.5K Sell
11,370
-1,856
-14% -$8.22K ﹤0.01% 3414
2024
Q4 		$87K Buy
13,226
+8,378
+173% +$66K ﹤0.01% 3323
2024
Q3 		$43.8K Buy
4,848
+288
+6% +$3.43K ﹤0.01% 3389
2024
Q2 		$73.1K Buy
+4,560
New +$66.2K ﹤0.01% 3228

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deutsche Bank's LXEO Position: Q2 2026 in Review

Deutsche Bank increased its Lexeo Therapeutics (LXEO) stake by 31% in Q2 2026, buying an estimated $104K and bringing the position to 82,293 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #2918.

Deutsche Bank first reported a position in LXEO in Q2 2024 and has held it in 9 quarters since. The position peaked at $568K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Deutsche Bank held 82,293 shares of Lexeo Therapeutics worth $383K as of Q2 2026.
  • Deutsche Bank bought 19,242 Lexeo Therapeutics shares in Q2 2026, an estimated $104K.
  • Lexeo Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2918 holding.
  • Deutsche Bank first reported a position in Lexeo Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Deutsche Bank's Lexeo Therapeutics position peaked at $568K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.